Ads
related to: sickle cell labs to monitor results- Mechanism Of Action
Learn About The LYFGENIA
MOA & How It Works.
- Treatment Pathway
Get An Overview Of The Treatment
Steps With LYFGENIA.
- FAQs
Get Answers To Questions
About Treatment With LYFGENIA.
- Support & Resources
Support For Your Patients During
Their Consideration & Treatment.
- Safety Information
Review Information On Adverse
Reactions & Additional Safety Data.
- Request A Representative
Fill Out The Online Form To Be
Contacted About LYFGENIA.
- Mechanism Of Action
Search results
Results From The WOW.Com Content Network
The sickle cell trait provides a survival advantage against malaria fatality over people with normal hemoglobin in regions where malaria is endemic. The trait is known to cause significantly fewer deaths due to malaria, especially when Plasmodium falciparum is the causative organism.
Photomicrograph of normal-shaped and sickle-shape red blood cells from a patient with sickle cell disease. Sickle cell anemia is a genetic disease that causes deformed red blood cells with a rigid, crescent shape instead of the normal flexible, round shape. [29] It is caused by a change in one nucleotide, a point mutation [30] in the HBB gene.
The acute chest syndrome is a vaso-occlusive crisis of the pulmonary vasculature commonly seen in people with sickle cell anemia. This condition commonly manifests with a new opacification of the lung(s) on a chest x-ray .
Fructosamines are compounds that result from glycation reactions between glucose and a primary amine, followed by isomerization via the Amadori rearrangement.Biologically, fructosamines are recognized by fructosamine-3-kinase, which may trigger the degradation of advanced glycation end-products (though the true clinical significance of this pathway is unclear).
Poikilocytosis may be diagnosed with a test called a blood smear.During a blood smear, a medical technologist/clinical lab scientist spreads a thin layer of blood on a microscope slide and stains the blood to help differentiate the cells.
Hemoglobin A2 (HbA 2) is a normal variant of hemoglobin A that consists of two alpha and two delta chains (α 2 δ 2) and is found at low levels in normal human blood.Hemoglobin A2 may be increased in beta thalassemia or in people who are heterozygous for the beta thalassemia gene.
Sickle Cell Anemia, a Molecular Disease" is a 1949 scientific paper by Linus Pauling, Harvey A. Itano, Seymour J. Singer and Ibert C. Wells that established sickle-cell anemia as a genetic disease in which affected individuals have a different form of the metalloprotein hemoglobin in their blood.
It is possible for a person to have both the gene for hemoglobin S (the form associated with sickle cell anemia) and the gene for hemoglobin C; this state is called hemoglobin SC disease, and is generally more severe than hemoglobin C disease, but milder than sickle cell anemia. [2]
Ad
related to: sickle cell labs to monitor results